ATNM ▼ -0.7% - Actinium Pharmaceuticals, Inc.
$ATNM - Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resistant Breast Cancer Models
02-NOV-2026 08:01 AM ET
Share this post
More filings for $ATNM
ATNM ▼ -3.3% - Actinium Pharmaceuticals, Inc.Oct 30, 2026ATNM ▲ +0.6% - Actinium Pharmaceuticals, Inc.Oct 23, 2026ATNM ▲ +3.0% - Actinium Pharmaceuticals, Inc.Oct 20, 2026ATNM ▲ +0.9% - Actinium Pharmaceuticals, Inc.Oct 19, 2026ATNM ▲ +4.8% - Actinium Pharmaceuticals, Inc.Oct 16, 2026ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.Oct 16, 2026
View full $ATNM filing history →💬 Comments
Loading comments…
Leave a comment